Clinical implication of multiple risk factor control in the management of diabetic macrovasucular complications.
Using cross-sectional and prospective analyses, the risk factors for macroangiopathy (MA) in nonobese Type 2 diabetic patients were evaluated. In the cross-sectional study, we determined a cutoff point for each variable at which changes in the prevalence of total MA reached statistically significant levels. In the prospective study, those who met more than four out of seven control criteria as set forth in the Multiclinical Study for Diabetic Macroangiopathy (MSDM) had less risk of MA in Type 2 diabetes initially diagnosed without MA compared with those who fulfilled less than three factors. These results suggest that multiple risk factor control is the most effective and reasonable way to lower the incidence of MA in Type 2 diabetes.
Suzuki
M
M
Department of Medicine, Division of Atherosclerosis, Metabolism, and Clinical Nutrition, National Cardiovascular Center, 5-7-1 Fujishirodai, Suita, 565-8565, Osaka, Japan.
Hattori
Y
Y
Takeuchi
M
M
Kimura
Y
Y
Yamazaki
Y
Y
Inada
H
H
Murase
O
O
Ito
H
H
Nawata
H
H
Orimo
H
H
Harano
Y
Y
D001786:Blood Glucose / Q000378:metabolism*; D001794:Blood Pressure; D015992:Body Mass Index; D003430:Cross-Sectional Studies; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology*; D003925:Diabetic Angiopathies / Q000453:epidemiology / Q000628:therapy*; D006801:Humans; D015994:Incidence; D007564:Japan / Q000453:epidemiology; D012307:Risk Factors
D001786:Blood Glucose